Nucleis, a biotechnological company focused on the creation of custom made transgenic mice, and RNAx announced the signing of a non-exclusive co-marketing agreement. Under the terms of the agreement RNAx provides Nucleis and its customers with in vitro shRNA validation technology to comple ... more
To use all functions of this page, please activate cookies in your browser.
